CA
PODD icon

Centerpoint Advisors’s Insulet PODD Stock Holding History

Centerpoint Advisors’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+75
New +$12.5K ﹤0.01% 326

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Centerpoint Advisors's PODD Position: Q2 2026 in Review

Centerpoint Advisors opened a new position in Insulet (PODD) in Q2 2026: 75 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #326 among its holdings.

722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Centerpoint Advisors held 75 shares of Insulet worth $11K as of Q2 2026.
  • Insulet was a new Centerpoint Advisors position in Q2 2026.
  • Insulet made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #326 holding.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.